Sign in
CompletedNo phase

Remote Alcohol Monitoring to Facilitate Abstinence From Alcohol: Exp 2

Key facts

Who runs it
Mikhail N Koffarnus
Where
Lexington and Roanoke, United StatesSee the 2 sites
Trial code
Status
Completed
People taking part
91 people enrolled
Started
15 Jul 2019
Ended
31 Aug 2026
Type of study
Interventional, 5 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Contingency Management
Record updated
8 October 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (4)Hide the full registry criteria

Who can take part

  • Recently completed or currently completing an alcohol detoxification program through the Carilion Clinic or University of Kentucky Healthcare system
  • Meet DSM-V criteria for alcohol use disorder
  • Abstinent from alcohol at the time of consent

Who cannot take part

  • Alcohol use disorder is secondary to another substance use disorder

Where in United States

  • University of Kentucky HealthCareLexington, United States
  • Virginia Tech CarilionRoanoke, United States

About the trial

What the trial wants to find out

Directly reinforcing abstinence from alcohol with monetary incentives is an effective treatment for alcohol dependence, but barriers in obtaining frequent, verified biochemical measures of abstinence limit the dissemination of this treatment approach. As our feasibility study demonstrates, remote breathalyzer monitoring drastically improves the practicality of delivering an alcohol contingency management intervention. In Experiment 2, we will test whether the addition of remote abstinence incentives to treatment as usual improves outpatient treatment outcomes and prevents relapse following inpatient detoxification at a regional hospital system. We will also assess whether readmission rates are reduced using a newly developed smartphone app and breathalyzer.

The 5 groups in the trial

  • Active Comparator: Group A (Intensive incentives)Existing treatment, for comparison

    Group A will have the opportunity to earn payments based on the results of their breathalyzer screens. Participants will receive a compliance incentive per submitted sample regardless of the results, but will also have the opportunity to earn more incentives for providing negative results. For the first 3 weeks, these additional incentives will scale based on the number of consecutive days of sustained negative samples. For the remaining weeks incentives will be based on a randomized "prize" drawing.

    Treatment: Contingency Management

  • Active Comparator: Group B (Prize-based incentives)Existing treatment, for comparison

    Group B will have the opportunity to earn payments based on the results of their breathalyzer screens. Participants will receive a compliance incentive per submitted sample regardless of the results, but will only have the opportunity to earn more incentives based on a randomized "prize" drawing if they submit a negative sample.

    Treatment: Contingency Management

  • Sham Comparator: Group C (Intensive incentives)Sham treatment, for comparison

    Group C serves as a direct control group to Group A and will follow the same incentive procedures, however participants will receive incentives regardless of the results of their samples.

    Treatment: Contingency management

  • Sham Comparator: Group D (Price-based incentives)Sham treatment, for comparison

    Group D serves as a direct control group to Group B and will follow the same incentive procedures, however participants will receive incentives regardless of the results of their samples.

    Treatment: Contingency management

  • No Intervention: Group E (no incentives)No study treatment, for comparison

    Group E will have no monitoring intervention, they will only complete assessment sessions.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Remote Alcohol Monitoring to Facilitate Abstinence Reinforcement With an Underserved Population
Record updated
8 October 2026